Bluebook
Diagnostics and Tools April 2024
2024 - April: Report on M&A and financing activity in the diagnostics and tools industry for CEOs and private equity professionals
Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
Highlights from this edition:
- Invitae Assets (Genetic Testing) was acquired by Labcorp
- Eurofins Scientific SE (ENXTPA:ERF) announced its acquisition of Ascend Clinical, LLC
- PinkDX closed a $40MM Series A Financing, led by Catalio Capital Management, LP